Neurodegeneration-Associated Microglia (NAM) are a specialized microglial phenotype identified through single-cell transcriptomics that emerges in response to chronic neurodegeneration. Unlike disease-associated microglia (DAM) or activated microglia, NAM represents a distinct cell state characterized by a specific gene expression signature associated with late-stage neurodegenerative processes[1].
Microglia are the resident immune cells of the central nervous system, derived from yolk sac progenitors early in embryogenesis. In the healthy brain, microglia perform essential homeostatic functions including synaptic pruning, debris clearance, and immune surveillance.
Under neurodegenerative conditions, microglia adopt multiple activation states. The NAM phenotype represents one of these states, characterized by a gene expression profile distinct from both homeostatic microglia and the DAM response seen in early Alzheimer's disease.
NAM cells are characterized by elevated expression of:
| Gene | Function | Significance |
|---|---|---|
| TREM2 | Triggering receptor on myeloid cells 2 | Lipid sensing, phagocytosis |
| TYROBP | TYROBP signaling adaptor | DAP12 co-receptor |
| CD33 | Siglec-3 receptor | Immunosuppression |
| APOE | Apolipoprotein E | Lipid transport, neurotoxicity |
| SPP1 | Osteopontin | Inflammation, cell migration |
| ITGAX | CD11c | Integrin alpha X |
| Feature | DAM (Stage 1-2) | NAM |
|---|---|---|
| TREM2 | Intermediate | High |
| APOE | Moderate | Very High |
| Type I IFN genes | Present | Absent |
| Proliferation genes | High | Low |
| Disease duration | Early | Chronic |
NAM microglia are prominently found in:
TREM2 genetic variants significantly influence NAM function:
Aβ/Lipid → TREM2 → TYROBP (DAP12) → SYK → PI3K → Phagocytosis
↓
Inflammation
| Strategy | Compound | Status |
|---|---|---|
| TREM2 agonist | AL002 | Phase 2 |
| TREM2 bispecific | TREM2xCD3 | Preclinical |
| Anti-APOE antibody | Aprinocarsen | Research |
The study of Neurodegeneration Associated Microglia (Nam) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.